Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Feb 20

PMID 20169076

Citations 19

Authors

Ali Bouamrani

Claire Ramus

Emmanuel Gay

Laurent Pelletier

Myriam Cubizolles

Sabine Brugiere

Didier Wion

Francois Berger

Jean-Paul Issartel

Affiliations

Soon will be listed here.

Abstract

Background: Tissue invasion or tissue infiltration are clinical behaviors of a poor-prognosis subset of meningiomas. We carried out proteomic analyses of tissue extracts to discover new markers to accurately distinguish between infiltrative and noninfiltrative meningiomas.

Methodology/principal Findings: Protein lysates of 64 different tissue samples (including two brain-invasive and 32 infiltrative tumors) were submitted to SELDI-TOF mass spectrometric analysis. Mass profiles were used to build up both unsupervised and supervised hierarchical clustering. One marker was found at high levels in noninvasive and noninfiltrative tumors and appeared to be a discriminative marker for clustering infiltrative and/or invasive meningiomas versus noninvasive meningiomas in two distinct subsets. Sensitivity and specificity were 86.7% and 100%, respectively. This marker was purified and identified as a multiphosphorylated form of vimentin, a cytoskeletal protein expressed in meningiomas.

Conclusions/significance: Specific forms of vimentin can be surrogate molecular indicators of the invasive/infiltrative phenotype in tumors.

Citing Articles

A Shotgun Proteomic-Based Approach with a Q-Exactive Hybrid Quadrupole-Orbitrap High-Resolution Mass Spectrometer for the Assessment of Pesticide Mixture-Induced Neurotoxicity on a 3D-Developed Neurospheroid Model from Human Brain Meningiomas:....

Louati K, Maalej A, Kolsi F, Kallel R, Gdoura Y, Borni M J Proteome Res. 2024; 23(12):5554-5576.

PMID: 39556108 PMC: 11629387. DOI: 10.1021/acs.jproteome.4c00804.

Interferon-induced MXB protein restricts vimentin-dependent viral infection.

Yi D, An N, Li Q, Liu Q, Shao H, Zhou R Acta Pharm Sin B. 2024; 14(6):2520-2536.

PMID: 38828143 PMC: 11143536. DOI: 10.1016/j.apsb.2024.03.029.

Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas.

Kuburich N, den Hollander P, Castaneda M, Pietila M, Tang X, Batra H Cell Rep. 2023; 42(12):113470.

PMID: 37979166 PMC: 11062250. DOI: 10.1016/j.celrep.2023.113470.

Molecular neuropathology of brain-invasive meningiomas.

von Spreckelsen N, Kesseler C, Brokinkel B, Goldbrunner R, Perry A, Mawrin C Brain Pathol. 2022; 32(2):e13048.

PMID: 35213084 PMC: 8877755. DOI: 10.1111/bpa.13048.

Comprehending Meningioma Signaling Cascades Using Multipronged Proteomics Approaches & Targeted Validation of Potential Markers.

Mukherjee S, Biswas D, Gadre R, Jain P, Syed N, Stylianou J Front Oncol. 2020; 10:1600.

PMID: 32974197 PMC: 7482667. DOI: 10.3389/fonc.2020.01600.

References

Zhang Z, Bast Jr R, Yu Y, Li J, Sokoll L, Rai A . Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004; 64(16):5882-90. DOI: 10.1158/0008-5472.CAN-04-0746. View

Bouamrani A, Ternier J, Ratel D, Benabid A, Issartel J, Brambilla E . Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem. 2006; 52(11):2103-6. DOI: 10.1373/clinchem.2006.070979. View

Yang H, Lieska N, Shao D, Kriho V, Pappas G . Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas. Mol Chem Neuropathol. 1994; 21(2-3):155-76. DOI: 10.1007/BF02815349. View

Gilles C, Polette M, Zahm J, Tournier J, Volders L, Foidart J . Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999; 112 ( Pt 24):4615-25. DOI: 10.1242/jcs.112.24.4615. View

Huang T, Lee T, Lee W, Lai Y, Yu J, Yang S . Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly. J Protein Chem. 1994; 13(6):517-25. DOI: 10.1007/BF01901533. View

Ando S, Tokui T, Yamauchi T, Sugiura H, Tanabe K, Inagaki M . Evidence that Ser-82 is a unique phosphorylation site on vimentin for Ca2(+)-calmodulin-dependent protein kinase II. Biochem Biophys Res Commun. 1991; 175(3):955-62. DOI: 10.1016/0006-291x(91)91658-y. View

Slawson C, Lakshmanan T, Knapp S, Hart G . A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol Biol Cell. 2008; 19(10):4130-40. PMC: 2555957. DOI: 10.1091/mbc.e07-11-1146. View

Nakamura Y, Kominami A, Tsujimoto Y, Nakayama Y, Kitahashi T, Yoshimoto S . Actin and Vimentin proteins with N-terminal deletion detected in tumor-bearing rat livers induced by intraportal-vein injection of Ha-ras-transfected rat liver cells. Int J Cancer. 2009; 124(11):2512-9. PMC: 2680316. DOI: 10.1002/ijc.24229. View

Whipple R, Balzer E, Cho E, Matrone M, Yoon J, Martin S . Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res. 2008; 68(14):5678-88. PMC: 2859318. DOI: 10.1158/0008-5472.CAN-07-6589. View

10.

Li Q, Spinelli A, Wang R, Anfinogenova Y, Singer H, Tang D . Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling. J Biol Chem. 2006; 281(45):34716-24. PMC: 1634890. DOI: 10.1074/jbc.M607715200. View

11.

Diamandis E . Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?. Clin Chem. 2003; 49(8):1272-5. DOI: 10.1373/49.8.1272. View

12.

Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, Cardol P . Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin. Biochem J. 2004; 383(Pt. 3):491-9. PMC: 1133742. DOI: 10.1042/BJ20040256. View

13.

Petricoin E, Liotta L . SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol. 2004; 15(1):24-30. DOI: 10.1016/j.copbio.2004.01.005. View

14.

Singh S, Sadacharan S, Su S, Belldegrun A, Persad S, Singh G . Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res. 2003; 63(9):2306-11. View

15.

Matsuzawa K, Kosako H, Inagaki N, Shibata H, Mukai H, Ono Y . Domain-specific phosphorylation of vimentin and glial fibrillary acidic protein by PKN. Biochem Biophys Res Commun. 1997; 234(3):621-5. DOI: 10.1006/bbrc.1997.6669. View

16.

Tsujimura K, Ogawara M, Takeuchi Y, Imajoh-Ohmi S, Ha M, Inagaki M . Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis. J Biol Chem. 1994; 269(49):31097-106. View

17.

Raymond W, Leong A . Vimentin--a new prognostic parameter in breast carcinoma?. J Pathol. 1989; 158(2):107-14. DOI: 10.1002/path.1711580205. View

18.

Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C . Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology. 2005; 41(1):40-7. DOI: 10.1002/hep.20505. View

19.

Wiesner A . Detection of tumor markers with ProteinChip technology. Curr Pharm Biotechnol. 2004; 5(1):45-67. DOI: 10.2174/1389201043489675. View

20.

Yung W, Luna M, Borit A . Vimentin and glial fibrillary acidic protein in human brain tumors. J Neurooncol. 1985; 3(1):35-8. DOI: 10.1007/BF00165169. View